(Q40853543)

24 September 2017

1 reference

title

Suramin: an anticancer drug with unique biological effects (English)

1 reference

24 September 2017

1 reference

A K Larsen

1

1 reference

PubMed ID

8387401

24 September 2017

language of work or name

1 reference

1 January 1993

1 reference

Cancer Chemotherapy and Pharmacology

24 September 2017

1 reference

24 September 2017

32

1 reference

24 September 2017

96-98

1 reference

24 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00685609

24 September 2017

0 references

cites work

Inhibition of vacuolar H+-ATPases by fusidic acid and suramin

1 reference

12 December 2020

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

12 December 2020

Suramin binds to platelet-derived growth factor and inhibits its biological activity

1 reference

12 December 2020

Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4

1 reference

12 December 2020

Intralysosomal accumulation of polyanions. II. Polyanion internalization and its influence on lysosomal pH and membrane fluidity.

1 reference

12 December 2020

Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

1 reference

12 December 2020

Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies

1 reference

12 December 2020

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

1 reference

12 December 2020

Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes

1 reference

12 December 2020

Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

1 reference

12 December 2020

Suramin. A potent inhibitor of melanoma heparanase and invasion

1 reference

12 December 2020

Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide

1 reference

12 December 2020

Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump

1 reference

12 December 2020

Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins

1 reference

12 December 2020

Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin.

1 reference

12 December 2020

Suramin: a potent inhibitor of the calcium transport in sarcoplasmic reticulum.

1 reference

12 December 2020

Suramin: With Special Reference to Onchocerciasis

1 reference

12 December 2020

Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression.

1 reference

12 December 2020

Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.

1 reference

12 December 2020

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

1 reference

12 December 2020

Inhibition by suramin of mitochondrial ATP synthesis

1 reference

12 December 2020

Suramin: an anticancer drug with a unique mechanism of action.

1 reference

12 December 2020

Circulating glycosaminoglycan anticoagulants associated with suramin treatment

1 reference

12 December 2020

Antiproliferative effects of suramin on lymphoid cells

1 reference

12 December 2020

Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells

1 reference

12 December 2020

Effect of suramin on the activities of degradative enzymes of sphingolipids in rats

1 reference

12 December 2020

Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group

1 reference

12 December 2020

Intralysosomal accumulation of polyanions. I. Fusion of pinocytic and phagocytic vacuoles with secondary lysosomes

1 reference

12 December 2020

The effects of antimicrobial agents on ribonucleic acid polymerase

1 reference

12 December 2020

Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism

1 reference

12 December 2020

Bovine brain-derived growth factor. Purification and characterization of its interaction with responsive cells

1 reference

12 December 2020

Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells

1 reference

12 December 2020

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

12 December 2020

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685609

1 reference

PubMed ID

8387401

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8387401